Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Laura Barrett Ryø"'
Autor:
Kristian Alsbjerg Skipper, Mathias Gaarde Nielsen, Sofie Andersen, Laura Barrett Ryø, Rasmus O. Bak, Jacob Giehm Mikkelsen
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 11, Iss C, Pp 253-262 (2018)
Continuous innovation of revolutionizing genome engineering technologies calls for an intensified focus on new delivery technologies that not only match the inventiveness of genome editors but also enable the combination of potent delivery and time-r
Externí odkaz:
https://doaj.org/article/4671060bb49b4a7b87deb58ccc646b58
Autor:
Maria Nascimento Primo, Emil Aagaard Thomsen, Xiaohong Tan, Ditte Starberg Jespersen, Anna Amanda Schönherz, Laura Barrett Ryø, Hanne Due, Martin Bøgsted, Karen Dybkær, Jacob Giehm Mikkelsen, Yuyang Pang, Anne Stidholt Roug, Ken H. Young, Min Xiao
Publikováno v:
Due, H, Schönherz, A A, Ryø, L, Primo, M N, Jespersen, D S, Thomsen, E A, Roug, A S, Xiao, M, Tan, X, Pang, Y, Young, K H, Bøgsted, M, Mikkelsen, J G & Dybkær, K 2019, ' MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma ', Blood advances, vol. 3, no. 7, pp. 1185-1196 . https://doi.org/10.1182/bloodadvances.2018029660
Due, H, Schönherz, A A, Ryø, L, Primo, M N, Jespersen, D S, Thomsen, E A, Roug, A S, Xiao, M, Tan, X, Pang, Y, Young, K H, Bøgsted, M, Mikkelsen, J G & Dybkær, K 2019, ' MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma ', Blood Advances, vol. 3, no. 7, pp. 1185-1196 . https://doi.org/10.1182/bloodadvances.2018029660
Due, H, Schönherz, A A, Ryø, L, Primo, M N, Jespersen, D S, Thomsen, E A, Roug, A S, Xiao, M, Tan, X, Pang, Y, Young, K H, Bøgsted, M, Mikkelsen, J G & Dybkær, K 2019, ' MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma ', Blood Advances, vol. 3, no. 7, pp. 1185-1196 . https://doi.org/10.1182/bloodadvances.2018029660
A major clinical challenge of diffuse large B-cell lymphoma (DLBCL) is that up to 40% of patients have refractory disease or relapse after initial response to therapy as a result of drug-specific molecular resistance. The purpose of the present study
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1961
Genetic information transferred by HIV-1-based lentiviral vectors as single-stranded RNA is converted to double-stranded DNA by reverse transcription and subsequently inserted into the genome of recipient cells. Integration into the genome allows sta
Autor:
Claus Koch, Anja Bille Bohn, Anette Bygum, Martin K. Thomsen, Kristian Alsbjerg Skipper, Iben Kløvgaard Rose, Tue Fryland, Lene N. Nejsum, Thomas J. Corydon, Sara Seidelin Majidi, Yaseelan Palarasah, Laura Barrett Ryø, Jacob Giehm Mikkelsen, Didde Haslund
Publikováno v:
Haslund, D, Ryø, L B, Majidi, S S, Christiansen, I R, Skipper, K A, Fryland, T, Bohn, A B, Koch, C, Thomsen, M K, Palarasah, Y, Corydon, T J, Bygum, A, Nejsum, L N & Mikkelsen, J G 2019, ' Dominant negative SERPING1 variants cause intracellular retention of C1-inhibitor in hereditary angioedema ', Journal of Clinical Investigation, vol. 129, no. 1, CI98869, pp. 388-405 . https://doi.org/10.1172/JCI98869
Haslund, D, Ryø, L B, Majidi, S S, Rose, I, Skipper, K A, Fryland, T, Bohn, A B, Koch, C, Thomsen, M K, Palarasah, Y, Corydon, T J, Bygum, A, Nejsum, L N & Mikkelsen, J G 2019, ' Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema ' Journal of Clinical Investigation, vol. 129, no. 1, CI98869 . https://doi.org/10.1172/JCI98869
Haslund, D, Ryø, L B, Seidelin Majidi, S, Rose, I K, Skipper, K A, Fryland, T, Bohn, A B, Koch, C, Thomsen, M K, Palarasah, Y, Corydon, T J, Bygum, A, Nejsum, L N & Mikkelsen, J G 2019, ' Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema ', Journal of Clinical Investigation, vol. 129, no. 1, CI98869, pp. 388-405 . https://doi.org/10.1172/JCI98869
Haslund, D, Ryø, L B, Majidi, S S, Rose, I, Skipper, K A, Fryland, T, Bohn, A B, Koch, C, Thomsen, M K, Palarasah, Y, Corydon, T J, Bygum, A, Nejsum, L N & Mikkelsen, J G 2019, ' Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema ' Journal of Clinical Investigation, vol. 129, no. 1, CI98869 . https://doi.org/10.1172/JCI98869
Haslund, D, Ryø, L B, Seidelin Majidi, S, Rose, I K, Skipper, K A, Fryland, T, Bohn, A B, Koch, C, Thomsen, M K, Palarasah, Y, Corydon, T J, Bygum, A, Nejsum, L N & Mikkelsen, J G 2019, ' Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema ', Journal of Clinical Investigation, vol. 129, no. 1, CI98869, pp. 388-405 . https://doi.org/10.1172/JCI98869
Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent edema attacks associated with morbidity and mortality. HAE results from variations in the SERPING1 gene that encodes the C1 inhibitor (C1INH), a serine protease i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c44b5988dde9c83fed5ad4a373ffd04d
https://pure.au.dk/portal/da/publications/dominant-negative-serping1-variants-cause-intracellular-retention-of-c1inhibitor-in-hereditary-angioedema(64c963cc-0bee-4c80-9386-013ba9d52d8f).html
https://pure.au.dk/portal/da/publications/dominant-negative-serping1-variants-cause-intracellular-retention-of-c1inhibitor-in-hereditary-angioedema(64c963cc-0bee-4c80-9386-013ba9d52d8f).html
Publikováno v:
Methods in Molecular Biology ISBN: 9781493991693
Genetic information transferred by HIV-1-based lentiviral vectors as single-stranded RNA is converted to double-stranded DNA by reverse transcription and subsequently inserted into the genome of recipient cells. Integration into the genome allows sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56a9a015b1fbddea4e0a75881dcda1f1
https://doi.org/10.1007/978-1-4939-9170-9_7
https://doi.org/10.1007/978-1-4939-9170-9_7
Autor:
Mathias Gaarde Nielsen, Jacob Giehm Mikkelsen, Sofie Andersen, Kristian Alsbjerg Skipper, Rasmus O. Bak, Laura Barrett Ryø
Publikováno v:
Skipper, K A, Nielsen, M G, Andersen, S, Ryø, L B, Bak, R O & Mikkelsen, J G 2018, ' Time-Restricted PiggyBac DNA Transposition by Transposase Protein Delivery Using Lentivirus-Derived Nanoparticles ', Molecular Therapy-Nucleic Acids, vol. 11, pp. 253-262 . https://doi.org/10.1016/j.omtn.2018.02.006
Molecular Therapy: Nucleic Acids, Vol 11, Iss C, Pp 253-262 (2018)
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 11, Iss C, Pp 253-262 (2018)
Molecular Therapy. Nucleic Acids
Continuous innovation of revolutionizing genome engineering technologies calls for an intensified focus on new delivery technologies that not only match the inventiveness of genome editors but also enable the combination of potent delivery and time-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197ec1ffb4ffcc2101024c316bb935f7
https://pure.au.dk/portal/da/publications/timerestricted-piggybac-dna-transposition-by-transposase-protein-delivery-using-lentivirusderived-nanoparticles(f31b2663-98e0-4afa-a859-6b68e8d96fbc).html
https://pure.au.dk/portal/da/publications/timerestricted-piggybac-dna-transposition-by-transposase-protein-delivery-using-lentivirusderived-nanoparticles(f31b2663-98e0-4afa-a859-6b68e8d96fbc).html
Autor:
Jacob Giehm Mikkelsen, Rune Hartmann, Sofie E. Jørgensen, Trine H. Mogensen, Mette Christiansen, Peter Staeheli, Jakob Gjedsted, Merete Storgaard, Laura Barrett Ryø, Hans Henrik Gad
Publikováno v:
Jørgensen, S E, Christiansen, M, Ryø, L B, Gad, H H, Gjedsted, J, Staeheli, P, Mikkelsen, J G, Storgaard, M, Hartmann, R & Mogensen, T H 2018, ' Defective RNA sensing by RIG-I in severe influenza virus infection ', Clinical and Experimental Immunology, vol. 192, no. 3, pp. 366-376 . https://doi.org/10.1111/cei.13120
Summary Influenza virus infection causes worldwide seasonal epidemics. Although influenza is usually a mild disease, a minority of patients experience very severe fulminating disease courses. Previous studies have demonstrated a role for type I inter